作者
Esmé Waanders, Zhaohui Gu, Stephanie M Dobson, Željko Antić, Jeremy Chase Crawford, Xiaotu Ma, Michael N Edmonson, Debbie Payne-Turner, Maartje van de Vorst, Marjolijn CJ Jongmans, Irina McGuire, Xin Zhou, Jian Wang, Lei Shi, Stanley Pounds, Deqing Pei, Cheng Cheng, Guangchun Song, Yiping Fan, Ying Shao, Michael Rusch, Kelly McCastlain, Jiangyan Yu, Ruben van Boxtel, Francis Blokzijl, Ilaria Iacobucci, Kathryn G Roberts, Ji Wen, Gang Wu, Jing Ma, John Easton, Geoffrey Neale, Scott R Olsen, Kim E Nichols, Ching-Hon Pui, Jinghui Zhang, William E Evans, Mary V Relling, Jun J Yang, Paul G Thomas, John E Dick, Roland P Kuiper, Charles G Mullighan
发表日期
2020/7/1
期刊
Blood Cancer Discovery
卷号
1
期号
1
页码范围
96-111
出版商
American Association for Cancer Research Journals
简介
Relapse of acute lymphoblastic leukemia (ALL) remains a leading cause of childhood cancer-related death. Prior studies have shown clonal mutations at relapse often arise from relapse-fated subclones that exist at diagnosis. However, the genomic landscape, evolutionary trajectories, and mutational mechanisms driving relapse are incompletely understood. In an analysis of 92 cases of relapsed childhood ALL incorporating multimodal DNA and RNA sequencing, deep digital mutational tracking, and xenografting to formally define clonal structure, we identified 50 significant targets of mutation with distinct patterns of mutational acquisition or enrichment. CREBBP, NOTCH1, and RAS signaling mutations arose from diagnosis subclones, whereas variants in NCOR2, USH2A, and NT5C2 were exclusively observed at relapse. Evolutionary modeling and xenografting demonstrated that relapse-fated …
引用总数
20202021202220232024638313611
学术搜索中的文章